Affinity Asset Advisors’s Cullinan Oncology CGEM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.99M | Hold |
263,817
| – | – | 0.27% | 52 |
|
2025
Q1 | $2M | Hold |
263,817
| – | – | 0.19% | 53 |
|
2024
Q4 | $3.21M | Hold |
263,817
| – | – | 0.43% | 43 |
|
2024
Q3 | $4.42M | Hold |
263,817
| – | – | 0.6% | 41 |
|
2024
Q2 | $4.6M | Buy |
263,817
+5,229
| +2% | +$91.2K | 0.53% | 41 |
|
2024
Q1 | $4.41M | Sell |
258,588
-41,412
| -14% | -$706K | 0.55% | 44 |
|
2023
Q4 | $3.06M | Buy |
+300,000
| New | +$3.06M | 0.56% | 41 |
|
2021
Q3 | – | Sell |
-45,000
| Closed | -$1.16M | – | 71 |
|
2021
Q2 | $1.16M | Buy |
+45,000
| New | +$1.16M | 0.41% | 43 |
|